Concord Healthcare Group Co., Ltd. Class H (HK:2453)
:2453
Want to see HK:2453 full AI Analyst Report?
2453 Stock Chart & Stats
HK$1.83
-HK$0.24(-2.76%)
At close: 4:00 PM EST
HK$1.83
-HK$0.24(-2.76%)
Day’s Range― - ―
52-Week RangeHK$1.02 - HK$7.91
Previous CloseN/A
Volume2.50M
Average Volume (3M)590.21K
Market Cap
HK$1.17B
Enterprise ValueHK$3.79B
Total Cash (Recent Filing)HK$319.01M
Total Debt (Recent Filing)HK$3.09B
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding313,874,630
10 Day Avg. Volume440,520
30 Day Avg. Volume590,206
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.62
Price to Sales (P/S)2.55
P/FCF Ratio-4.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound & Improving Gross MarginA 21% revenue rebound and a shift to a positive gross margin indicate the business can restore top-line growth and improve core unit economics. If sustained, improved margins reduce cash burn per unit sold and create a clearer path toward operating leverage and eventual profitability over several quarters.
Improved Leverage And Positive EquityA reduction in debt/equity and positive equity provides greater solvency and financing optionality. Lower leverage versus prior year reduces refinancing pressure and interest burden, giving management more time to execute strategy and lowering the probability of distress if operating performance stabilizes.
Demonstrated Ability To Generate Operating CashHistorical positive operating cash flow shows the underlying care-facilities model can convert revenue into cash when operations are controlled. This proves operational cash conversion potential, meaning management can drive liquidity improvement through cost discipline or scale rather than relying solely on external funding.
Bears Say
Deep And Persistent Operating LossesVery large negative EBIT and net margins indicate the company remains structurally loss-making. Such persistent operating losses erode retained capital, constrain reinvestment, and require ongoing funding or restructuring. Without sustained margin recovery, profitability remains an uncertain multi-quarter outcome.
Negative Operating And Free Cash FlowConsecutive years of negative operating cash flow and a materially negative free cash flow indicate the business currently consumes liquidity. This drives reliance on external financing or asset sales, increases funding risk, and reduces headroom for strategic investments or weathering demand shocks over the next several quarters.
Elevated Leverage With Negative ReturnsModerately high debt combined with negative ROE shows capital is not generating adequate returns, amplifying financial strain. Elevated leverage limits flexibility to fund operations or invest, raises refinancing and interest-rate risk, and magnifies the impact of any further earnings shortfall on solvency.
Concord Healthcare Group Co., Ltd. Class H News
2453 FAQ
What was Concord Healthcare Group Co., Ltd. Class H’s price range in the past 12 months?
Concord Healthcare Group Co., Ltd. Class H lowest stock price was HK$1.02 and its highest was HK$7.91 in the past 12 months.
What is Concord Healthcare Group Co., Ltd. Class H’s market cap?
Concord Healthcare Group Co., Ltd. Class H’s market cap is HK$1.17B.
When is Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date?
Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date is Aug 27, 2026 which is in 104 days.
How were Concord Healthcare Group Co., Ltd. Class H’s earnings last quarter?
Concord Healthcare Group Co., Ltd. Class H released its earnings results on Mar 26, 2026. The company reported -HK$0.112 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.112.
Is Concord Healthcare Group Co., Ltd. Class H overvalued?
According to Wall Street analysts Concord Healthcare Group Co., Ltd. Class H’s price is currently Overvalued.
Does Concord Healthcare Group Co., Ltd. Class H pay dividends?
Concord Healthcare Group Co., Ltd. Class H does not currently pay dividends.
What is Concord Healthcare Group Co., Ltd. Class H’s EPS estimate?
Concord Healthcare Group Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Concord Healthcare Group Co., Ltd. Class H have?
Concord Healthcare Group Co., Ltd. Class H has 313,874,630 shares outstanding.
What happened to Concord Healthcare Group Co., Ltd. Class H’s price movement after its last earnings report?
Concord Healthcare Group Co., Ltd. Class H reported an EPS of -HK$0.112 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.167%.
Which hedge fund is a major shareholder of Concord Healthcare Group Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2453
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concord Healthcare Group Co., Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.59%
12-Months-Change
Fundamentals
Return on Equity
-15.15%
Trailing 12-Months
Asset Growth
2.55%
Trailing 12-Months
Company Description
Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and medical institutions in China. It also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support; and operating lease services. The company was incorporated in 2008 and is headquartered in Beijing, China. Concord Healthcare Group Co., Ltd operates as a subsidiary of Shanghai Medstar Financial Leasing Company.
Technical Analysis
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―